株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

OTC医薬品市場:商業的動向とスイッチOTC医薬品の見通し

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

発行 CBR Pharma Insights 商品コード 349969
出版日 ページ情報 英文 67 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
OTC医薬品市場:商業的動向とスイッチOTC医薬品の見通し The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
出版日: 2015年12月14日 ページ情報: 英文 67 Pages
概要

レポートでは、OTCスイッチから消費者、支払者、製造業者が受ける恩恵、OTC医薬品の使用を促進する要因などについて調査し、将来的見通しと法規制の枠組み、市場におけるM&A動向などをまとめています。

イントロダクション

世界のOTC医薬品市場における動向

OTC医薬品市場におけるM&A活動

OTC医薬品市場の促進因子

OTC医薬品市場の障壁

OTC医薬品およびOTCスイッチを取り巻く現行の法規制

  • 米国
  • 欧州
  • アジア太平洋地域

OTC医薬品市場における近年の法規制動向

  • 米国
  • 欧州
  • アジア太平洋地域

取組みや法規制(NSURE、Affordable Care Act)が将来のOTCスイッチに及ぼす影響

OTCスイッチケーススタディ:主なメリット、経済的および財政的影響

OTC医薬品市場およびOTCスイッチの将来動向

  • 将来のOTCスイッチに向けた薬剤候補
  • 大手のOTC医薬品剤メーカーと関心分野
  • OTCスイッチ戦略の重要性
    • ライフサイエンス企業
    • 製薬会社
    • その他

OTC医薬品市場における主要製品カテゴリー

  • 咳、風邪、アレルギー
  • 鎮痛
  • 皮膚
  • 消化管
    • 主要ブランドと製造業者

付録

参考情報

目次
Product Code: GBI064CBR

Summary

GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets. Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval. Detailed case studies of recent Rx-to-OTC switches provide the rationale for these switches including description of their economic and financial impact.

The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. GBI Research expects M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios. A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets. The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years.

GBI Research conducted extensive primary and secondary research efforts in order to provide a comprehensive view of the regulatory, commercial and competitive landscape in the OTC drugs market. Our new report will let you assess the most promising commercial areas in the market and help you identify key opportunities and challenges.

Scope

  • How do consumers, payers and manufacturers benefit from Rx-to-OTC switches?
  • What are the key factors promoting the usage of OTC drugs?

Current trends in the OTC drugs market

  • What attitudes do consumers have towards OTC drugs?
  • How are new distribution channels, technologies and education reshaping the OTC drugs market?
  • What will be the impact of new regulatory initiatives and frameworks on future Rx-to-OTC switches in key markets?
  • What have been the preferred types of M&A deals in the OTC drugs market in recent years?
  • Which OTC drug manufacturers have been the most active in terms of mergers and acquisitions in recent years?
  • What are the current regulations and frameworks established in key developed and developing markets for OTC approval and Rx-to-OTC switches?
  • Which OTC drug product categories and drug classes have experienced the most switches in recent years?
  • Which new products categories are expected to enter the OTC drugs market in the coming years?
  • What has been the economic and financial impact of recent Rx-to-OTC switches?
  • Who are the leading OTC drug manufacturers and what are their OTC segments of interest?

Market analysis of the leading OTC product categories including cough, cold, and allergy, analgesics, gastrointestinal and dermatological drugs.

Key Reasons to Purchase

This report will allow you to -

  • Gain insights into the OTC drugs market and future prospects for Rx-to-OTC switches: This report comprehensively describes and assesses the commercial, regulatory and competitive landscape in this highly dynamic and lucrative industry.
  • Understand differing regulatory frameworks for OTC drugs and Rx-to-OTC switches in key markets: This report provides insights about established regulatory processes, approval frameworks and recent developments in the US, Europe, Japan, India and China for OTC drugs.
  • Assess M&A activity in the OTC drugs market: This report provides detailed analysis on M&A deals in recent years including trends on preferred types of deals, factors contributing to the surge in transactions and identifies the most active companies in the OTC drugs market.
  • Assess the market for the leading OTC product categories: Our new study provides market analyses of the key product categories including revenues in key national markets, key brands, key manufacturers, market drivers, restraints, recent switches and potential candidates for future Rx-to-OTC switch.

Table of Contents

  • Introduction
  • Key Global Trends in the OTC Drugs Market
    • US
    • Europe
    • APAC (India, China, Japan)
  • M&A Activity in the OTC Drugs Market: Leading Companies Consolidating their Market Position
    • Deal Analysis by Value, Type and Subtype
  • Drivers of the OTC Drugs Market
  • Barriers of the OTC Drugs Market
  • Current Regulations Surrounding OTC Drugs and Rx-to-OTC Switches
    • US
    • Europe
    • APAC
  • Recent Regulatory Trends and Developments in the OTC Drugs Market
    • US
    • Europe
    • APAC
  • Impact of Initiatives and Regulations (NSURE, Affordable Care Act) on Future Rx-to-OTC Switches
  • Rx-to-OTC Switch Case Studies: Key Benefits, Economic and Financial Impact
    • Nexium 24HR
    • Nasacort Allergy 24HR
    • Rhinocort Nasal Spray
    • Oxytrol For Women
    • Nicotine Replacement Therapies
  • Future Trends in the OTC Drugs Market and Rx-to-OTC Switches
    • Potential Drug Candidates for Future Rx-to-OTC Switch
    • Leading OTC Drug Manufacturers and Segments of Interest
    • Importance of Rx-to-OTC Strategies
      • Life Sciences Companies
      • Pharmacies
      • Others
  • Leading Product Categories in the OTC Drugs Market
    • Cough, Cold and Allergy OTC Drugs
      • Leading Brands and Key Manufacturers
      • Market Analysis
    • Analgesic OTC Drugs
      • Leading Brands and Key Manufacturers
      • Market Analysis
    • Dermatology OTC Drugs
      • Leading Brands and Key Manufacturers
      • Market Analysis
    • Gastrointestinal OTC Drugs
      • Leading Brands and Key Manufacturers
      • Market Analysis
  • Appendix
  • Bibliography
Back to Top